Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
methylprednisolonnatriumsuccinat |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone acetate |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone adverse reaction |
Causative agent |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone measurement |
Has measured component |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone measurement |
Component |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
methylprednisolonnatriumsuccinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Product containing methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Allergy to methylprednisolone |
Causative agent |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonacetat 80 mg/2 ml+ lidocainhydrochlorid 20 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonacetat 40/1 ml + lidocainhydrochlorid 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 50 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 500 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 40 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 125 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 500 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 1 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolon 2 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing methylprednisolone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing methylprednisolone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
methylprednisolonnatriumsuccinat 40 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 500 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 2 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone sodium succinate 500g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone sodium su 40mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg/2 ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 40 mg/ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
methylprednisolonnatriumsuccinat 125 mg injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone sodium su 125mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone sodium succinate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Intramuscular injection of methylprednisolone (procedure) |
Direct substance |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing methylprednisolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Intramuscular injection of methylprednisolone (procedure) |
Direct substance |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Intramuscular injection of methylprednisolone (procedure) |
Direct substance |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone pulse therapy |
Direct substance |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Allergy to methylprednisolone |
Causative agent |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Allergy to methylprednisolone |
Causative agent |
False |
Methylprednisolone |
Inferred relationship |
Some |
2 |
Methylprednisolone aceponate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 16 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone hemisuccinate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone hemisuccinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone sodium succinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone aceponate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methylprednisolone |
Inferred relationship |
Some |
|
Methylprednisolone 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone 16 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing lidocaine and methylprednisolone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing only methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone and neomycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing only lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing only methylprednisolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing only methylprednisolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Lidocaine and methylprednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
methylprednisolon 1 g pulver til injektionsvæske, opløsning, hætteglas |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
methylprednisolon 1 g pulver til injektionsvæske, opløsning, hætteglas |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methylprednisolone |
Inferred relationship |
Some |
1 |